Alcon, the global leader in eye care, announced today the acquisition of Endure Medical Systems, a company specialized in advanced technology surgical microscopes. More
Alcon, the global leader in eye care and a division of Novartis, announced today that it has gained exclusive rights to commercialize ocriplasmin outside the United States for the treatment of symptomatic vitreomacular adhesion (VMA). If approved, it will More